超声引导星状神经节阻滞与胸椎旁阻滞用于慢性上肢疼痛交感阻滞的多中心前瞻性随机比较
多中心前瞻性随机研究比较超声引导胸椎旁阻滞(TPVB)与星状神经节阻滞(SGB)对慢性上肢疼痛的交感阻滞成功率;
要点
- TPVB组术后20分钟ΔT差值和疼痛缓解均优于SGB组。
- 两组疼痛在术后1周和4周均回升至干预前水平。
核心结论
- 超声引导TPVB的上肢交感阻滞成功率高于超声引导SGB,且术后即刻疼痛缓解更明显。
研究设计与样本
- 多中心前瞻性随机对照研究,纳入19至85岁慢性上肢疼痛(复杂区域疼痛综合征和神经病理性疼痛)患者,随机分入US-guided TPVB组(T2椎旁注射1%甲哌卡因10 mL)或US-guided SGB组(C6水平注射1%甲哌卡因5 mL)。
主要发现
- 两组成功率差异为24.6%(95%CI,-9.0%至58.2%)。
关键数值与推荐
- 交感阻滞成功的预设标准为术后20分钟患侧与健侧手温差(ΔT差值)≥1.5°C。
临床怎么用
- 对于慢性上肢疼痛患者,超声引导TPVB可作为SGB的替代方案以获得更高的交感阻滞成功率和更明显的术后即刻疼痛缓解。
- 需注意两种阻滞的疼痛缓解均短暂,术后1周和4周疼痛回升至基线,需结合其他长期管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stellate ganglion block (SGB) is a type of sympathetic block used to relieve pain in the face and upper extremities. However, its effectiveness can be limited by the presence of Kuntz fibers that bypass the stellate ganglion. Thoracic paravertebral block (TPVB) offers an alternative in such cases. We hypothesized that ultrasound (US)-guided TPVB would provide a higher success rate of upper extremity sympathetic blockade than US-guided SGB. Therefore, this prospective randomized study aimed to compare the technical success rates between US-guided TPVB and US-guided SGB and assess clinical outcomes in alleviating upper extremity pain. METHODS: Patients aged 19 to 85 years diagnosed with chronic upper extremity pain (complex regional pain syndrome and neuropathic pain) were randomly assigned to either the US-guided TPVB group, where they received a 10 mL injection of 1% mepivacaine in the T2 paravertebral space, or the US-guided SGB group, where they received a 5 mL injection of 1% mepivacaine at the C6 level. The primary outcome was the success rate (%) of sympathetic blockade, which was predefined as the difference in temperature change between affected and unaffected hands 20 minutes after the procedure (ΔT difference) of ≥ 1.5°C. Secondary outcomes included comparisons of the ΔT difference (°C), differences in peak systolic velocities (cm/s) of the ipsilateral brachial artery at 20 minutes, and pain intensity at baseline and 20 minutes, 1 week, and 4 weeks after the procedure using an 11-point numerical rating scale (NRS) pain score. RESULTS: The TPVB group (N = 22/35, 62.9%) showed a higher success rate than the SGB group (N = 13/34, 38.2%; P = .041) in achieving the primary outcome of sympathetic blockade at 20 minutes. The difference in success rates between the 2 groups was 24.6 % (95% confidence interval [CI], -9.0% to 58.2%). The ΔT difference was significantly higher in TPVB than in SGB (2.0°C ±1.5 and 1.1°C ±1.3, respectively; P = .008). The peak systolic velocities at 20 minutes increased in TPVB (P = .005), which was not observed in SGB (P = .325). Pain intensity decreased in both groups 20 minutes after injection (P < .001 in each group), and the TPVB group showed a lower 11-point NRS pain score compared to the SGB group (4.3 ± 2.2 and 5.4 ± 2.4, respectively; P = .038). Pain intensity scores increased to preintervention levels in both groups at 1 week and 4 weeks after the interventions. CONCLUSIONS: US-guided TPVB had a higher success rate of upper extremity sympathetic blockade than US-guided SGB, with more pronounced immediate postprocedural pain relief.
引用
- Kim J, Cha J, Choi SN, et al. Multicenter Prospective Randomized Comparison of Ultrasound-Guided Stellate Ganglion Versus Thoracic Paravertebral Block for Sympathetic Blockade in Chronic Upper Extremity Pain. Anesth Analg. 2024. PMID: 39976623. doi:10.1213/ANE.0000000000007014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。